Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Natera revenue
Natera's revenue is $820.2 million.
What is Natera's revenue?
- Natera has 975 employees, and the revenue per employee ratio is $841,253.
- Natera peak revenue was $820.2M in 2024.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Natera financial information
| CEO | Stephen Chapman |
| Industry | Software & Services |
| Company Type | Public |
| Employees Number | 975 |
| Date Founded | 2004 |
| Headquarters | San Carlos, California |
| Number of Locations | 4 |
| Revenue | $820.2M |
| Net Income | -$547,799,000 |
| Market Capitalization | $584.9M |
| Total Assets | $1,394,474,000 |
| Ticker | NTRA |
Natera jobs you might like
Natera financing
Natera received early financing of $4.0M on 2008-12-05.
| Series | Round size | Date |
|---|---|---|
| Series A | $4M | 12/2008 |
| Series B | $6M | 01/2009 |
| Series C | $12M | 11/2010 |
| Grant | $2M | 04/2011 |
| Series D | $20M | 01/2012 |
| Series E | $54.6M | 05/2013 |
| Series F | $55.5M | 04/2015 |
| Post Ipo Equity | $250M | 04/2020 |
| Post Ipo Equity | $5M | 03/2022 |
Natera investors
| Investors | Security type |
|---|---|
| Claremont Creek Ventures | Series A |
| Sequoia Capital | Series A |
| Claremont Creek Ventures | Series B |
| Alafi Capital | Series B |
| Sequoia Capital | Series B |
| Sequoia Capital | Series C |
| National Institutes of Health (NIH) | Grant |
| Claremont Creek Ventures | Series D |
| Lightspeed Venture Partners | Series D |
| Sequoia Capital | Series D |
| Claremont Creek Ventures | Series E |
| Harmony Partners | Series E |
| OrbiMed Advisors | Series E |
| Founders Fund | Series E |
| Lightspeed Venture Partners | Series E |
| Sequoia Capital | Series E |
| Jennison Associates | Series F |
| HealthCor Partners | Series F |
| Franklin Resources, Inc. | Series F |
| SOFINNOVA INVESTMENTS INC | Series F |
| OrbiMed Advisors | Series F |
| RA Capital Management | Series F |
| Sequoia Capital | Series F |
| Matthew Rabinowitz | Post Ipo Equity |
| Roelof Botha | Post Ipo Equity |
Natera competitors
Natera's top competitor, Johnson & Johnson, earned an annual revenue of $88.8B.
Natera's smallest competitor is Access Cardinal Health System with revenue of $5.4M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Seagen | $85,008 | $2.0B | 900 | - |
| Moderna | $81,825 | $3.2B | 2,500 | 83 |
| ZymoGenetics | $90,249 | $27.0M | 200 | - |
| Neurocrine Biosciences | $78,232 | $2.4B | 400 | 426 |
| Nektar Therapeutics | $83,561 | $98.4M | 718 | - |
| Boston Scientific | $60,291 | $16.7B | 36,000 | 876 |
| Incyte | $103,592 | $4.2B | 1,600 | 39 |
| Johnson & Johnson | $76,686 | $88.8B | 134,500 | 1,759 |
| Vertex Pharmaceuticals | $95,952 | $11.0B | 3,400 | 269 |
| Maxygen | $71,411 | $30.0M | 8 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Natera highest paying jobs
Zippia gives an in-depth look into the details of Natera, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Natera. The employee data is based on information from people who have self-reported their past or current employments at Natera. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Natera. The data presented on this page does not represent the view of Natera and its employees or that of Zippia.
Natera may also be known as or be related to Natera, Natera Inc, Natera Inc. and Natera, Inc.